Explore more publications!

Daily Healthcare St. Lucia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Daily Healthcare St. Lucia.

Press releases published on March 12, 2026

PracticeLink Launches 2026 Webinar Series for Healthcare Recruiters
NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026
Longeveron to Report 2025 Full-Year Financial Results and Host Conference Call on March 17, 2026
Signati™ Medical Announces Dr. LeRoy Jones Has Been Appointed as a Professor of Urology at the University of Texas San Antonio
PROCEPT BioRobotics® Announces International Launch of the HYDROS® Robotic System, Expanding Global Access to AI-Enabled Aquablation® Therapy
Capricor Therapeutics Announces Late-Breaking HOPE-3 Data at the 2026 MDA Conference Demonstrating Significant Functional Benefits of Deramiocel for Duchenne Muscular Dystrophy
Trinity Biotech Begins Rollout of Innovative Glucose Monitoring System In Key Market Following Regulatory Approval of Next-Generation Premier Hb9210 HbA1c Column System
Just Salad Opens Drive-Thru in Norwalk, Connecticut
Propanc Biopharma Targets $3B+ Pancreatic Cancer Market with PRP: 85%+ Tumor Inhibition in Breakthrough Proenzyme Therapy
NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products
Easy Environmental Solutions surges to great start in first quarter of 2026
20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies
ORAGENICS INITIATES PHASE IIA CLINICAL TRIAL SITE ACTIVATION
Pelthos Therapeutics to Present at 38th Annual ROTH Conference
FibroBiologics Announces Advances in Burn Treatment Using Proprietary Fibroblast Spheroid Technology
Xilio Therapeutics Announces 1-for-14 Reverse Stock Split
Ultragenyx Announces Positive 36-Week Data from Phase 3 Study of DTX301 AAV8 Gene Therapy for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency
Polaryx Therapeutics Deepens Engagement with the Krabbe Disease Community Through Scientific and Patient Advocacy Events
Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities
CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions